You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Dow
Medtronic
McKinsey
Colorcon
Mallinckrodt
AstraZeneca

Last Updated: March 28, 2020

DrugPatentWatch Database Preview

Litigation Details for HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2015)


Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

Small Molecule Drugs cited in HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC.
The small molecule drugs covered by the patents cited in this case are   Start Trial and   Start Trial .

Details for HORIZON MEDICINES LLC v. DR. REDDY'S LABORATORIES INC. (D.N.J. 2015)

Date Filed Document No. Description Snippet Link To Document
2019-11-08 231 motion, when filed, concerned six patents: U.S. Patent Nos. 8,852,636, 8,858,996, 8,865,190, 9,161,920…U.S. Patent No. 8,858,996 (the “’996 patent”) and claims 1-5, 7-9, 11-14 of U.S. Patent No. …’s claims for those patents from the six patents that do not involve the patent claims included in Plaintiffs…. 9,161,920 (the “’920 patent”) (collectively, “the Asserted Patents”) to be asserted in this…Asserted Patents.” This motion, then, concerns the identified claims in the Asserted Patents only. External link to document
2019-12-18 252 arose. The two patents presently at issue descend from U.S. Patent No. 6,926,907: U.S. Patent Nos. 8,858,996…litigation involved U.S. Patent Nos. 6,926,907 and 8,557,285.2 Those patents 1 DRL has filed ANDA…prosecution history of a parent patent, the ‘907 patent. The ‘920 and ‘996 patents descended from the application…litigation regarding patents related to the drug Vimovo®. Plaintiff Nuvo owns the patents, Plaintiff Horizon…8,858,996 (the “’996 patent”) and 9,161,920 (the “’920 patent”). APPLICABLE External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
McKinsey
Dow
Baxter
Merck
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.